Literature DB >> 33922808

Passive Immunity and Antibody Response Induced by Toxoplasma gondii VLP Immunization.

Hae-Ji Kang1, Min-Ju Kim1, Ki-Back Chu1, Su-Hwa Lee2, Eun-Kyung Moon2, Fu-Shi Quan2,3.   

Abstract

Passive immunity can provide immediate protection against infectious pathogens. To date, only a few studies have investigated the effect of passive immunization against Toxoplasma gondii, and the use of immune sera acquired from VLP-vaccinated mice for passive immunity assessment remains unreported. In this study, immune sera were produced by a single immunization with virus-like particles (VLPs) expressing the inner membrane complex (IMC), rhoptry protein 18 (ROP18), and microneme protein 8 (MIC8) of Toxoplasma gondii, with or without a CpG-ODN adjuvant. The passive immunization of immune sera conferred protection in mice, as indicated by their potent parasite-specific antibody response, lessened brain cyst counts, lower bodyweight loss, and enhanced survival. In order to confirm that the immune sera of the VLP-immunized mice were truly protective, the antibody responses and other immunological parameters were measured in the VLP-immunized mice. We found that VLP immunization induced higher levels of parasite-specific IgG, IgG subclass, and IgM antibody responses in the sera and intestines than in the controls. Enhanced Th1 and Th2-associated cytokines in the spleen, diminished brain cyst counts, and lessened body weight loss were found following T. gondii ME49 challenge infection. These results suggest that passive immunization with the immune sera acquired from VLP-vaccinated mice can confer adequate protection against T. gondii infection.

Entities:  

Keywords:  CpG-ODN; Toxoplasma gondii; antibody response; cytokine; virus-like particle

Year:  2021        PMID: 33922808     DOI: 10.3390/vaccines9050425

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  47 in total

1.  CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii.

Authors:  H Kringel; J P Dubey; E Beshah; R Hecker; J F Urban
Journal:  Vet Parasitol       Date:  2004-08-13       Impact factor: 2.738

2.  Administration of substances to laboratory animals: routes of administration and factors to consider.

Authors:  Patricia V Turner; Thea Brabb; Cynthia Pekow; Mary Ann Vasbinder
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

3.  Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection.

Authors:  Su-Hwa Lee; Hae-Ji Kang; Dong-Hun Lee; Sang-Moo Kang; Fu-Shi Quan
Journal:  Vaccine       Date:  2018-08-11       Impact factor: 3.641

4.  Studies of active and passive immunity in animals inoculated with Toxoplasma gondii.

Authors:  B G Foster; W F McCulloch
Journal:  Can J Microbiol       Date:  1968-02       Impact factor: 2.419

Review 5.  Passive and active immunization against respiratory syncytial virus for the young and old.

Authors:  Tonya Villafana; Judith Falloon; M Pamela Griffin; Qing Zhu; Mark T Esser
Journal:  Expert Rev Vaccines       Date:  2017-06-07       Impact factor: 5.217

6.  Mucosal adjuvants for influenza virus-like particle vaccine.

Authors:  Fu-Shi Quan; Eun-Ju Ko; Young-Man Kwon; Kyoung Hwan Joo; Richard W Compans; Sang-Moo Kang
Journal:  Viral Immunol       Date:  2013-11-16       Impact factor: 2.257

Review 7.  Toxoplasmosis in sheep--the last 20 years.

Authors:  J P Dubey
Journal:  Vet Parasitol       Date:  2009-03-13       Impact factor: 2.738

Review 8.  A review on human toxoplasmosis.

Authors:  Geita Saadatnia; Majid Golkar
Journal:  Scand J Infect Dis       Date:  2012-07-25

9.  Protection against experimental toxoplasmosis by adoptive immunotherapy.

Authors:  C S Pavia
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

10.  Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes.

Authors:  Rabie M Mohamed; Fumie Aosai; Mei Chen; Hye-Seong Mun; Kazumi Norose; Usama S Belal; Lian-Xun Piao; Akihiko Yano
Journal:  Vaccine       Date:  2003-06-20       Impact factor: 3.641

View more
  2 in total

1.  Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice.

Authors:  Keon-Woong Yoon; Ki-Back Chu; Hae-Ji Kang; Min-Ju Kim; Gi-Deok Eom; Su-Hwa Lee; Eun-Kyung Moon; Fu-Shi Quan
Journal:  Front Cell Infect Microbiol       Date:  2021-09-29       Impact factor: 5.293

2.  Application of Convolutional Neural Network in Motor Bearing Fault Diagnosis.

Authors:  Shuiqin Zhou; Lepeng Lin; Chu Chen; Wenbin Pan; Xiaochun Lou
Journal:  Comput Intell Neurosci       Date:  2022-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.